Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Genprex Inc. (GNPX)

  • Business News
  • Jan. 07, 2026, 12:05 UTC
  • 10
  • 1 comments

Genprex Provides Clinical Update on Diabetes Gene Therapy Program

Market reaction Comment Full text

10X Genomics Inc (TXG)

  • Business News
  • Jan. 07, 2026, 12:05 UTC
  • 12
  • 1 comments

10x Genomics - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Market reaction Comment Full text

Caredx Inc (CDNA)

  • Business News
  • Jan. 07, 2026, 12:05 UTC
  • 11
  • 1 comments

CareDx - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Market reaction Comment Full text

Caredx Inc (CDNA)

  • Business News
  • Jan. 07, 2026, 12:05 UTC
  • 9
  • 1 comments

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Market reaction Comment Full text

10X Genomics Inc (TXG)

  • Business News
  • Jan. 07, 2026, 12:05 UTC
  • 12
  • 1 comments

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Market reaction Comment Full text

Evogene Ltd (EVGN)

  • Business News
  • Jan. 07, 2026, 12:04 UTC
  • 10
  • 1 comments

Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders

Market reaction Comment Full text

Veeva Systems Inc (VEEV)

  • Business News
  • Jan. 07, 2026, 12:03 UTC
  • 12
  • 1 comments

Novo Nordisk International Operations Commits to Veeva Vault CRM

Market reaction Comment Full text

Rezolute Inc. (RZLT)

  • Business News
  • Jan. 07, 2026, 12:00 UTC
  • 11
  • 1 comments

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Market reaction Comment Full text

Gain Therapeutics Inc. (GANX)

  • Business News
  • Jan. 07, 2026, 12:00 UTC
  • 6
  • 1 comments

Gain Therapeutics Announces Conference Participation During J.P. Morgan Healthcare Conference Week

Market reaction Comment Full text

Avient Corp (AVNT)

  • Business News
  • Jan. 07, 2026, 12:00 UTC
  • 15
  • 1 comments

Avient To Hold Fourth Quarter 2025 Conference Call

Market reaction Comment Full text
  • Previous
  • 374
  • 375
  • 376
  • 377
  • 378
  • Next

Search

News categories

  • Technical Exchange News(11010)
  • Event(2494)
  • SEC News(194936)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126795)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin